Introduction {#Sec1}
============

The anterior part of the telencephalon of larval *Xenopus laevis* is primarily involved in the processing of olfactory information. It mainly consists of the olfactory bulb (OB), the first relay center of the olfactory system. This structure processes chemosensory stimuli detected in the peripheral olfactory organs and transfers this information to higher brain centers \[[@CR1]\]. The basic organization of the OB is highly conserved across phyla \[[@CR2]\]. From the surface to the center, the OB can be subdivided in six discernible layers: the nerve layer, the glomerular layer, the external plexiform layer, the mitral cell layer, the internal plexiform layer and the granule cell layer. The most caudal layer, the granule cell layer, contacts the lateral telencephalic ventricles, which in larval *X. laevis* expand deep into the anterior telencephalon \[[@CR3]\]. The area surrounding the lateral ventricles, the so-called periventricular zone (PVZ), has been reported to be a neurogenic region comprising neuronal stem cells \[[@CR4]\]. Recent studies have shown that the proliferating cells of the PVZ of the lateral ventricles in larval and adult *X. laevis* are homologous to neural stem cells of higher vertebrates \[[@CR3]\]. In mammals, the cells of the embryonic and adult PVZ of many brain regions have been thoroughly characterized \[[@CR5]--[@CR8]\]. In lower vertebrates such as amphibians, comparable detailed studies are lacking.

Extracellular nucleotides act via purinergic receptors, which have been divided in two main families: adenosine or P1 receptors and P2 receptors \[[@CR9]\]. The P1 receptors all couple to G proteins and have been further subdivided into four subtypes (A~1~, A~2A~, A~2B~, and A~3~). The P2 receptors have been split into ionotropic P2X receptors and G protein coupled P2Y receptors. To date, seven subtypes of P2X receptors (P2X~1~--P2X~7~) and eight subtypes of P2Y receptors (P2Y~1~, P2Y~2~, P2Y~4~, P2Y~6~, P2Y~11~, P2Y~12~, P2Y~13~, and P2Y~14~) have been described \[[@CR10]--[@CR12]\]. An additional P2Y receptor, named P2Y~8~, with an extremely broad agonist selectivity has been cloned from *X. laevis* embryos \[[@CR13]\]. Activation of purinergic receptors has been shown to play an important role in many physiological processes \[[@CR14]\], including embryonic and adult neurogenesis \[[@CR14], [@CR15]\] and neuron--glia interactions in the OB \[[@CR16]\]. It has been shown, mainly by means of immunohistochemical studies, that purinergic receptors and associated nucleotide-degrading enzymes are expressed in the murine OB and PVZ \[[@CR14], [@CR15]\]. However, a thorough functional study of the purinergic system of these two brain regions is as yet missing, and to our knowledge in non-mammalian vertebrates there are no studies at all.

In the present study, we described the ultrastructural organization of the PVZ of larval *X. laevis*, and determined the proliferation rates of its neuronal stem cells. We then identified and investigated the purinergic system of the OB and its neurogenic PVZ and demonstrate that activation of purinergic receptors initiates stereotypic Ca^2+^ signaling in cells of both brain areas. Thereby, we found that cells of the two brain areas express different purinergic receptor subtypes. Also, we obtained evidence that the purinergic receptors expressed in the OB are not evidently involved in the immediate processing of olfactory information. Possible physiological roles of the purinergic system in the OB and the PVZ are discussed.

Materials and methods {#Sec2}
=====================

Slices of the anterior telencephalon and nose--brain preparations {#Sec3}
-----------------------------------------------------------------

Larval *X. laevis* (stages 51 to 54; staged after \[[@CR17]\]) were cooled to produce complete immobility, and then killed by transection of the brain at its transition to the spinal cord. All procedures for animal handling and tissue dissections were carried out according to the guidelines of the Göttingen University Committee for Ethics in Animal Experimentation. For slices of the anterior telencephalon, a block of tissue containing the terminal part of the olfactory nerves and the anterior brain was cut out. Then, the tissue was glued onto the stage of a vibroslicer (VT 1000S, Leica, Bensheim, Germany), cut horizontally into one 120--130 μm thick slice and kept in bath solution. For nose--brain preparations a block of tissue containing the olfactory epithelia, the olfactory nerves and the anterior part of the brain was cut out and kept in bath solution. The tissue was then glued onto the stage of the vibroslicer and only the dorsal surface of the OB was sliced off. The olfactory epithelia were left intact. For a more detailed description of these preparations see earlier work of our lab \[[@CR18], [@CR19]\] and Figs. [3](#Fig3){ref-type="fig"} and [8](#Fig8){ref-type="fig"}.

Solutions, staining protocol, and stimulus application {#Sec4}
------------------------------------------------------

Standard bath solution consisted of (in mM): 98 NaCl, 2 KCl, 1 CaCl~2~, 2 MgCl~2~, 5 glucose, 5 Na-pyruvate, 10 HEPES, 230 mOsmol/l, pH 7.8. Ca^2+^-free bath solution consisted of (in mM): 98 NaCl, 2 KCl, 2 MgCl~2~, 5 glucose, 5 Na-pyruvate, 10 HEPES, 2 EGTA, 230 mOsmol/l, pH 7.8.

Tissue preparations were transferred to a recording chamber, and bath solution containing 50 μM Fura-2/AM (Molecular Probes, Leiden, The Netherlands) was added. Fura-2/AM was dissolved in DMSO (Sigma, Deisenhofen, Germany) and Pluronic F-127 (Molecular Probes). The final concentrations of DMSO and Pluronic F-127 did not exceed 0.5% and 0.1%, respectively. Cells of the nervous system of larval *X. laevis* express multidrug transporters \[[@CR20], [@CR21]\] with a wide substrate spectrum, including calcium-indicator dyes. To avoid transporter-mediated destaining of the slices, 50 μM MK571 (Alexis Biochemicals, Grünberg, Germany), an inhibitor of multidrug transporters was added to the incubation solution. The preparations were incubated on a shaker at room temperature for 35 min.

5-Bromo-2′-deoxyuridine (BrdU); adenosine; adenosine-5′-diphosphate (ADP); adenosine-5′-triphosphate (ATP); uridine; uridine-5′-triphosphate (UTP); α,β-methylene-ATP (α,β-MeATP); β,γ-methylene-ATP (β,γ-MeATP); 2-methylthio-ATP (2MeSATP); 3′-*O*-(4-benzoyl)benzoyl ATP (BzATP); suramin, pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), [d]{.smallcaps}(−)-2-amino-5-phosphonopentanoic acid (APV) and bath solution chemicals were purchased from Sigma.

As odorants, we used a mixture of 15 [l]{.smallcaps}-amino acids (glycine, alanine, serine, threonine, cysteine, valine, leucine, isoleucine, methionine, proline, arginine, lysine, histidine, phenylalanine, and tryptophan, all from Sigma, each at a concentration of 100 μM).

Bath solution was applied by gravity feed from a storage syringe through a funnel drug applicator to the recording chamber. In the experiments with slices of the anterior telencephalon, the purinergic agonists were pipetted directly into the funnel (placed above the anterior telencephalon) without stopping the flow. In all experiments with the nose--brain preparation, odorants were pipetted directly into the funnel drug applicator placed above the intact olfactory epithelium. An additional bath solution applicator for application of purinergic agonists and antagonists was positioned above the OB (see Fig. [8](#Fig8){ref-type="fig"}). Outflow was through a syringe needle placed at the height of the olfactory nerves in both preparations.

Ca^2+^ imaging and data evaluation {#Sec5}
----------------------------------

For calcium imaging, Fura-2-stained preparations were fixed with a grid in a recording chamber and placed on the stage of an upright microscope (Axioskop 2, Zeiss, Göttingen, Germany). Fluorescence images (excitation at 380 nm; emission \>505 nm) were recorded using a frame-transfer, back-illuminated CCD camera (16 bits/pixel, Micromax; Visitron, München, Germany) and a custom-built monochromator. With this configuration intracellular calcium concentration \[Ca^2+^\]~i~ increases are accompanied by a decrease of the Ca^2+^-dependent fluorescence. Images were acquired at 200 to 500 ms exposure time per image using the commercial image acquisition software Winview (Visitron). Before starting the imaging experiments, the slices were rinsed with bath solution for at least 5 min.

Image analysis was performed using custom programs written in MATLAB (MathWorks, Natick, USA). To facilitate selection of regions of interest, a "pixel correlation map" was obtained by calculating the cross-correlation between the fluorescence signals of a pixel to that of its immediate neighbors and then the resulting values were displayed as a grayscale map. The fluorescence changes for individual regions of interest are given as ∆*F*/*F* values. For more detailed information see our previous work \[[@CR22]\]. Because some slices showed a linear loss of fluorescence intensity over time (bleaching artifacts) the ∆*F*/*F* values used to present all averaged data, presented as mean ± SEM (standard error of the mean), were corrected to retain comparability. On the basis of the first ten and the last four data points of each recording a linear fitting was calculated using MATLAB functions and subtracted from the raw data. For the calculation of the proliferation rate, series of brain slices (70 μm thickness, two to four slices per animal) were prepared, and multiple fields of view were visualized to include the whole PVZ of both sides. Cell nuclei labeled with propidium iodide and BrdU were counted automatically using CellProfiler \[[@CR23]\]. Counting results were verified by inspecting overlays of automatically identified objects on the original images.

BrdU injections and histology {#Sec6}
-----------------------------

To stain cells in the S phase of their cell cycle, larval *X. laevis* (stages 51 to 54) were anesthetized, and 200 μM BrdU, a synthetic nucleoside that is an analogue of thymidine \[[@CR24]\], was injected intraperitoneally. After 16--18 h additional 200 μM BrdU were injected to sustain high BrdU levels. After 24 h the animals were sacrificed and a tissue block containing the anterior part of the brain was removed. For BrdU-immunohistochemistry, the removed tissue blocks were fixed in 4% formaldehyde, washed in phosphate buffer saline (PBS), embedded in 5% low melting point agarose (Sigma) and sectioned on the vibratome at 70 μm. Sections were washed in PBS containing 0.2% Triton X-100 (PBST), and non-specific binding was blocked with 2% normal goat serum (NGS; ICN, Aurora, Ohio, USA) in PBST for 1 h at room temperature. The slices were then incubated in 1 N HCl at 37°C for 45 min to denature DNA. Subsequently, the slices were incubated overnight at 4°C with primary antibodies \[anti BrdU (B2531, monoclonal, derived from mouse, Sigma) diluted in 2% NGS/PBST (1:1,000)\]. The primary antibodies were washed off with PBS and Alexa 488 conjugated goat anti mouse secondary antibodies (Molecular Probes) were applied at a dilution of 1:250 in 1% NGS/PBS for 2 h at room temperature. The secondary antibodies were washed off in several changes of PBS. Cell nuclei were stained with propidium iodide.

For purinergic receptor immunohistochemistry, formaldehyde fixed brains were washed in PBS, embedded in 5% low melting point agarose (Sigma), and subsequently sectioned on the vibratome at 70 μm. Sections were then washed in PBST, and non-specific binding was blocked with 2% NGS in PBST for 1 h at room temperature. Tissue was then incubated overnight at 4°C with the primary antibodies \[anti rat P2X~1~, anti rat P2X~2~, anti rat P2X~4~, anti rat P2X~7~, anti rat P2Y~2~, and anti rat P2Y~4~ (1:200, raised in rabbit, Alomone Labs, Jerusalem, Israel\] diluted in 2% NGS/PBST. Primary antibodies were washed off with PBS, and Alexa 488 conjugated goat anti rabbit secondary antibodies (Molecular Probes) were applied at a dilution of 1:250 in 1% NGS/PBS for 2 h at room temperature. The secondary antibody was washed off in several changes of PBS. The specificity of the anti P2 receptor antibodies used was previously assessed by the producer and evaluated in *X. laevis* by incubating slices with the anti P2 antibodies (1:200) preadsorbed, 1 h at room temperature, with the immunizing peptide provided by the producer.

Slices were then transferred to slides and mounted in mounting medium (Daco, Hamburg, Germany). Images were acquired with a confocal laser-scanning microscope (Zeiss LSM 510/Axiovert 100 M, Jena, Germany).

For transmission electron microscopy, specimens were fixed with 1.5% glutaraldehyde and 1.5% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.3 for 3 h at room temperature and then postfixed for 2 h in 2% osmium tetroxide in 0.1 M sodium phosphate buffer. Samples were embedded in Araldite after dehydration in graded ethanol. To obtain a general overview of the samples semithin sections (1 μm) were cut with an Ultracut E (Leica), mounted on micro slides and stained with Methylenblue-Azur II for 1 min and viewed under an Axioplan 2 (Zeiss, Oberkochen, Germany) to which an Axiocam MRc 5 (Zeiss) was attached. Ultrathin sections were cut with an Ultracut E (Leica), mounted on copper grids, poststained with uranyl acetate and lead citrate and viewed under a LEO 900 (Zeiss).

Results {#Sec7}
=======

Description of the neurogenic PVZ of the anterior telencephalon {#Sec8}
---------------------------------------------------------------

A general overview of the telencephalon of larval *X. laevis* is given in Fig. [1a](#Fig1){ref-type="fig"}. To investigate the ultrastructural organization of the cell layers surrounding the lateral telencephalic ventricles we performed transmission electron microscopy. Figure [1b](#Fig1){ref-type="fig"} (b~1~) shows the anterior part of the lateral telencephalic ventricle, the PVZ and the posterior part of the granule cell layer of the OB. The transition between the anterior PVZ, adjacent to the OB, and the granule cell layer can be clearly identified (dotted line). Generally, the cells within the PVZ appear more electron dense than those in the adjacent cells layers. The neuronal stem-/progenitor cells within the anterior PVZ are arranged in four to five cell layers with irregular or oval nuclei that present, in some cases, small invaginations and prominent nucleoli (Fig. [1b, b](#Fig1){ref-type="fig"}~2~). Thereby, the cells contacting the ventricular lumen do not apparently differ from those within the other cell layers and are devoid of cilia or microvilli. The asterisk shows a neuronal stem-/progenitor cell in mitosis. Highly condensed DNA (chromosomes) is clearly visible showing that cells in the PVZ proliferate. The cell bodies of the granule cells have a more regular, roundish shape. The medial PVZ is made of about three to four cell layers and its cells basically resemble those of the anterior PVZ (Fig. [1b, b](#Fig1){ref-type="fig"}~3~). Some of them also have prominent nucleoli and they feature chromatin in different states of aggregation, probably representing pre- or postmitotic stages of the cell cycle. As in the anterior part of the PVZ, also here the cells in direct contact with the lateral ventricle do not bear cilia or microvilli. The PVZ situated laterally to the ventricle appears thinner than in the anterior and medial part (Fig. [1b, b](#Fig1){ref-type="fig"}~4~). It is composed of more tightly packed cells arranged in at most two cell layers. Most cells have elongated nuclei and are devoid of cilia or microvilli. Figure [1b](#Fig1){ref-type="fig"} (b~5~ and b~6~) depicts higher magnification images of PVZ cells, two of them in mitosis, contacting the lumen of the lateral ventricle. The luminal parts of the cells are tightly packed with mitochondria. One cell exhibits a large cytoplasmic protrusion into the lumen of the ventricle; another cell exhibits a multivesicular protrusion expanding into the ventricle. This image shows also one of the rare cells extending a single cilium into the cerebrospinal fluid. Fig. 1Ultrastructural analysis of the anterior telencephalon. **a** Horizontal slice of the telencephalon of larval *X. laevis* stained with Methylenblue-Azur II. **b** Transmission electron microscopy of the anterior part of the lateral telencephalic ventricles with its PVZ and the posterior part of the granule cell layer of the OB (*b*~*1*~). Various electron micrographs were assembled into a photo montage to obtain this overview. The *dotted line* indicates the approximate border between the PVZ and the granule cell layer of the OB. The *brackets* indicate the approximate location of the areas shown at higher magnification in b~2~ through b~4~. Anterior part of the PVZ and adjacent granule cell layer of the OB (*b*~*2*~). Cell divisions are frequent in the PVZ. Note the cell with decomposed nuclear envelope and condensed DNA in form of chromosomes (*asterisk*). Medial part of the PVZ (*b*~*3*~) and lateral part of the PVZ (*b*~*4*~). The *brackets in b*~*2*~*through b*~*4*~ include the cell layers of the anterior, medial, and lateral PVZ, respectively. b~5~ shows a higher magnification of cells in direct contact with the lumen of the lateral ventricles. Two cells are in mitosis (*asterisks*). The *white arrows* indicate accumulations of mitochondria very close to the ventricular lumen. The *black arrow* shows a large cellular protrusion into the ventricle. The area included in the bracket is shown at higher magnification in b~6~. Note the multivesicular protrusion into the ventricle (*arrowhead*) and the single cilium extending into the cerebrospinal fluid (*arrow*). Abbreviations: *ON* olfactory nerve, *OB* olfactory bulb, *PVZ* periventricular zone, *TEL* telencephalon, *CP* choroid plexus, *lv* lateral ventricle, *gcl* granule cell layer

To determine the proliferation rate of the PVZ cells and to further define the border between the neurogenic PVZ and the adjacent OB, we combined propidium iodide cell nuclei staining and a BrdU incorporation assay. In the adopted survey time window (see the "[Materials and methods](#Sec2){ref-type="sec"}" section) the BrdU-positive cells, i.e., the proliferating cells, were confined to the PVZ. This helped to determine the approximate borders between the two brain regions (Fig. [2](#Fig2){ref-type="fig"}). Thereby, we found that the proliferation rate of PVZ cells is rather high. 42.54 ± 6.65% (SEM; *n* = 3 animals, 6 OBs/PVZs) of all cells surrounding the lateral ventricles were BrdU-positive. Fig. 2Cells in the periventricular zone of the lateral ventricle actively proliferate. **a** Schematic representation of the anterior telencephalon of larval *X. laevis*. **b** Overview over a horizontal section of the anterior telencephalon (*b*~*1*~) in which all cell nuclei were stained with propidium iodide (*red fluorescence*) and proliferating cells were visualized with a BrdU incorporation assay (*green fluorescence*). Proliferating cells appear yellow. Higher magnification of the periventricular region of different animals (*b*~*2-1*~--*b*~*2-3*~ and *b*~*3*~). Abbreviations: *ON* olfactory nerve, *MOB* main olfactory bulb, *AOB* accessory olfactory bulb, *PVZ* periventricular zone, *gl* glomerular layer/glomeruli, *mcl* mitral cell layer, *gcl* granule cell layer, *lv* lateral ventricle, *pc* periglomerular cells

Nucleotide-induced increases of \[Ca^2+^\]~i~ in cells of the anterior telencephalon {#Sec9}
------------------------------------------------------------------------------------

Figure [3a](#Fig3){ref-type="fig"} (a~1~--a~3~) show a larva of *X. laevis*, a slice preparation of its telencephalon and a slice of the anterior part of the telencephalon stained with the fluorescent calcium-indicator dye Fura-2, respectively. To visualize nucleotide-induced \[Ca^2+^\]~i~ signals in cells of the anterior telencephalon, we performed calcium imaging experiments. Figure [3b](#Fig3){ref-type="fig"} (b~1~) shows the same slice as in Fig. [3a](#Fig3){ref-type="fig"} (a~3~), with the red-shaded area covering the OB and the green shaded area covering the PVZ. Application of 5 μM 2MeSATP led to specific transient cellular response patterns in the vast majority of cells (Fig. [3b, b](#Fig3){ref-type="fig"}~2~). The response time courses of six individual cells of the OB and six cells of the PVZ are plotted in Fig. [3b](#Fig3){ref-type="fig"} (b~3~--b~4~). Figure [3b](#Fig3){ref-type="fig"} (b~5~) shows the mean (±SEM) intracellular Ca^2+^ transients of all 2MeSATP-responsive cells of this OB and PVZ. Application of ATP (50 μM) to the same slice preparation elicited similar, though smaller \[Ca^2+^\]~i~ transients (Fig. [3b, b](#Fig3){ref-type="fig"}~6~). Similar results were obtained in more than 20 slices of the anterior telencephalon tested for their responsiveness to 2MeSATP and ATP. These results strongly suggest that both, OB cells and PVZ cells, are endowed with purinergic receptors. To exclude purinergic receptor desensitization, interstimulus intervals of at least 5 min were chosen in all of the experiments. Fig. [3c](#Fig3){ref-type="fig"} shows that ATP-induced \[Ca^2+^\]~i~ increases remain stable using this experimental protocol. Fig. 3Nucleotide-induced \[Ca^2+^\]~i~ increases in cells of the anterior telencephalon. **a** Overview of a head of larval *X. laevis* (*a*~*1*~). The *black rectangle* indicates the location of the anterior telencephalon. An acute slice preparation of the telencephalon is shown in *a*~*2*~. The black rectangle indicates the approximate location of the Fura-2/AM stained slice shown in a~3~ (*brightened fluorescence image acquired at rest*). **b** Fura-2/AM stained slice preparation (the same as shown in a~3~) with the area of the OB shaded in *red*, and the PVZ shaded in *green* (*b*~*1*~). Pixel correlation map of the same slice (see "[Materials and methods](#Sec2){ref-type="sec"}" section for details) obtained upon application of 2MeSATP (5 μM; b~2~). The ventricle appears to respond as a whole. This results from responses of ependymal cells from the floor of the lateral ventricle. The 2MeSATP-induced \[Ca^2+^\]~i~ transients of six individual cells of the OB (see *black dots in the red-shaded area* in b~1~) and the PVZ (see *black dots in the green shaded area* in b~1~) are shown in b~3~ and b~4~, respectively. The 2MeSATP-induced mean \[Ca^2+^\]~i~ transients (±SEM) of all clearly identifiable responsive cells of the OB (*red traces*; *n* = 138) and the cells of the PVZ (*green traces*; *n* = 32) of this slice are shown in b~5~. Application of ATP (50 μM) to the same slice preparation induced comparable \[Ca^2+^\]~i~ transients in the same cells as above (*b*~*6*~). (**c**) Mean \[Ca^2+^\]~i~ transients of responding OB and PVZ cells (*n* = 120) remain stable after repeated applications of ATP (100 μM; interstimulus interval: 5 min). Abbreviations: *OE* olfactory epithelium, *AT* anterior telencephalon, *ON* olfactory nerve, *MOB* main olfactory bulb, *AOB* accessory olfactory bulb, *PVZ* periventricular zone, *gl* glomerular layer/glomeruli, *mcl* mitral cell layer, *gcl* granule cell layer, *lv* lateral ventricle

To confirm that the nucleotide-induced responses were truly mediated by purinergic receptors, we tested the effects of two acknowledged P2 receptor antagonists. In both brain regions, the OB and the PVZ, 2MeSATP- and ATP-induced \[Ca^2+^\]~i~ increases were reduced in presence of suramin (200 μM; Fig. [4a and b](#Fig4){ref-type="fig"}) and PPADS (200 μM; Fig. [4c and d](#Fig4){ref-type="fig"}). Nevertheless, the observed effect of suramin on 2MeSATP-induced responses in both brain regions and on ATP-induced responses in the PVZ was not statistically significant. It has been shown that glutamate mediates most or all excitatory synaptic interactions between OB cells via ionotropic receptors \[[@CR1], [@CR25]\], and extracellular nucleotides acting on purinergic receptors have been shown to be able to induce glutamate release from neuronal \[[@CR26], [@CR27]\] and glial cells \[[@CR26], [@CR28], [@CR29]\]. To exclude a contribution of ionotropic glutamate receptors in the \[Ca^2+^\]~i~ increases recorded in cells of the anterior telencephalon, we tested the effect of the AMPA and NMDA receptor antagonist CNQX and APV. Figure [4e](#Fig4){ref-type="fig"} and [f](#Fig4){ref-type="fig"} show that the ATP-induced peak responses remained virtually unchanged in both regions when the ionotropic glutamate receptors were blocked. Fig. 4Effects of purinergic and glutamatergic antagonists on nucleotide-induced \[Ca^2+^\]~i~ increases in cells of the anterior telencephalon. **a** Mean peak responses (±SEM), expressed as percent of control response to 2MeSATP (100 μM), of 186 OB cells and 80 PVZ cells (three slices of the anterior telencephalon) in control conditions (*red and green columns on the left-hand side*, respectively), after 10 min in bath solution with 200 μM suramin (*light red and light green column*, respectively), and after 10 min of washout with bath solution (*red and green columns on the right-hand side*, respectively). **b** Same representation as in **a** with ATP (100 μM) and suramin \[200 μM; 90 OB cells and 72 PVZ cells (two and three slices of the anterior telencephalon, respectively)\]. **c** Same representation as in **a** with 2MeSATP (10 μM) and PPADS \[200 μM; 155 OB cells and 216 PVZ cells (two slices of the anterior telencephalon)\]. **d** Same representation as in **a** with ATP (50 μM) and PPADS \[200 μM; 242 OB cells and 262 PVZ cells (three slices of the anterior telencephalon)\]. **e** The peak amplitudes of ATP-induced (100 μM) mean \[Ca^2+^\]~i~ transients (±SEM) of all responsive cells (OB: *n* = 21, *red traces*; PVZ: *n* = 47, *green traces*) of an individual slice of the anterior telencephalon are not significantly attenuated by 50 μM CNQX and 200 μM APV (OB: *light red trace*; PVZ: *light green trace*). **f** Mean peak responses (±SEM), expressed as percent of control response to ATP (100 μM), of 287 OB cells and 360 PVZ cells (seven slices of the anterior telencephalon) in control conditions (*red and green columns on the left-hand side*, respectively), after 5 min in bath solution with 50 μM CNQX and 200 μM APV (*light red and light green column*, respectively), and after 10 min of washout with bath solution (*red and green columns on the right-hand side*, respectively). (\**p* \< 0.05 and \*\**p* \< 0.01; unpaired *t* test)

To test whether metabotropic and/or ionotropic purinergic receptors are expressed in the OB and the PVZ, we performed experiments with Ca^2+^-free extracellular bath solution. Although in both brain regions, 2MeSATP- and ATP-induced \[Ca^2+^\]~i~ increases were significantly reduced in Ca^2+^-free bath solution, the reduction was consistently greater in the OB (Fig. [5](#Fig5){ref-type="fig"}). PVZ cells of all slices tested clearly retained some residual responses. After returning to standard bath solution, the responses recovered almost completely. This set of data unambiguously shows that OB cells are endowed almost exclusively with ionotropic P2X receptor(s), while PVZ cells in addition to an important fraction of ionotropic P2X receptors most likely express also some metabotropic purinergic receptors. Fig. 5Nucleotide-induced responses of OB and PVZ cells are differentially affected by omission of extracellular Ca^2+^. **a** Fura-2/AM stained acute slice preparation of the anterior telencephalon (*a*~*1*~; image acquired at rest). The area of the OB is *shaded in red*, and the area of the PVZ is *shaded in green*. Pixel correlation maps of the same slice (see "[Materials and methods](#Sec2){ref-type="sec"}" section for details) obtained upon application of 2MeSATP (100 μM; *a*~*2*~ standard bath solution; *a*~*3*~ application after 10 min in Ca^2+^-free bath solution; *a*~*4*~ application after returning to standard bath solution). **b** The corresponding 2MeSATP-induced mean \[Ca^2+^\]~i~ transients (±SEM) of all clearly identifiable responsive cells of the OB \[*b*~*1*~*red traces*: in normal bath solution (before and after application of Ca^2+^-free bath solution); *light red traces*: after 10 min in Ca^2+^-free bath solution; *n* = 82 cells\] and of the PVZ \[*b*~*2*~*green traces*: in normal bath solution (before and after application of Ca^2+^-free bath solution); *light green traces*: after 10 min in Ca^2+^-free bath solution; *n* = 59 cells\]. **c** Mean peak responses (±SEM), expressed as percent of control response to 2MeSATP (10 μM), of 161 OB cells and 182 PVZ cells (two slices of the anterior telencephalon) in control conditions (*red and green columns*, respectively) and after 10 min in Ca^2+^-free bath solution (*light red and light green column*, respectively). **d** Same representation as in C with 2MeSATP \[100 μM; 205 OB cells and 105 PVZ cells (two slices of the anterior telencephalon)\]. **e** Same representation as in C with ATP \[50 μM; 161 OB cells and 182 PVZ cells (two slices of the anterior telencephalon)\]. (\**p* \< 0.05 and \*\**p* \< 0.01; unpaired *t* test). Abbreviations: *MOB* main olfactory bulb, *lv* lateral ventricle

To substantiate the above results and to obtain an indication of which purinergic receptor subtypes are expressed in the OB and the PVZ, we examined the potency of nine purinergic agonists known to differentially activate purinergic receptor subtypes, and compared their efficacy to elicit \[Ca^2+^\]~i~ increases in cells of these brain regions. The obtained results are shown in Fig. [6](#Fig6){ref-type="fig"}. Thereby, the most evident differences were observed with adenosine and ADP. While these two agonists were almost ineffective in the OB, they induced clear \[Ca^2+^\]~i~ increases in cells of the PVZ. Also ATP induced significantly stronger responses in cells of the PVZ, but in contrast to adenosine and ADP, it induced clear responses also in the OB. 2MeSATP and BzATP elicited strong \[Ca^2+^\]~i~ increases in cells of both regions. While 2MeSATP was almost equipotent in the OB and the PVZ, BzATP was more effective in the OB. α,β-MeATP, β,γ-MeATP, uridine and UTP were inactive or very weakly active in both regions. Fig. 6Responsiveness of OB and PVZ cells to purinergic receptor agonists. **a** Mean \[Ca^2+^\]~i~ transients (±SEM) of all clearly identifiable responsive cells of an OB (*red traces*) and a PVZ (*green traces*). Traces originate from more than one tissue slice. **b** The mean peak amplitude of agonist-induced responses (±SEM) of cells of the OB and the PVZ were compared (*red columns* OB cells, green columns *PVZ cells*). \[adenosine (100 μM), data from 170 OB cells and 236 PVZ cells from 6 slices of the anterior telencephalon; ADP (100 μM), 245 OB cells and 154 PVZ cells from three slices; ATP (50 μM), 1566 OB cells and 1303 PVZ cells from 28 and 23 slices, respectively; 2MeSATP (100 μM), 378 OB cells and 285 PVZ cells from five slices; BzATP (50 μM), 213 OB cells and 93 PVZ cells from four and two slices, respectively; α,β-MeATP (50 μM), 310 OB cells and 198 PVZ cells from six and three slices, respectively; β,γ-MeATP (100 μM), 387 OB cells and 318 PVZ cells from seven and six slices, respectively; uridine (100 μM), 275 OB cells and 308 PVZ cells from six slices; UTP (100 μM), 335 OB cells and 324 PVZ cells from five slices\]. (\**p* \< 0.05 and \*\**p* \< 0.01; unpaired *t* test). Abbreviations: *ADP* adenosine-5′-diphosphate, *ATP* adenosine-5′-triphosphate, *UTP* uridine-5′-triphosphate; *α,β-MeATP* α,β-methylene-ATP, *β,γ-MeATP* β,γ-methylene-ATP, *2MeSATP* 2-methylthio-ATP, *BzATP*, 3′-*O*-(4-benzoyl)benzoyl ATP

Immunohistochemical localization of purinergic receptors {#Sec10}
--------------------------------------------------------

To gain additional information about the purinergic receptor subtypes expressed in the anterior telencephalon, we employed antibody stainings. We obtained positive results with antibodies against P2X~7~ and the P2X~4~ subtypes. Preincubation with the immunizing peptide specifically blocked the staining. P2X~7~- and P2X~4~-like immunoreactivity was found on cells of both the OB and the PVZ. Antibodies against the P2X~7~ receptor subtype showed a somatic staining pattern in cells of both the OB and the PVZ (Fig. [7a](#Fig7){ref-type="fig"}). Antibodies against the P2X~4~ receptor subtype showed a clear somatic staining pattern in OB cells (Fig. [7b, b](#Fig7){ref-type="fig"}~1~). Interestingly, higher magnification pictures of the PVZ revealed a positive P2X~4~-like staining of tubular structures starting from the ependymal layer of the lateral ventricle and extending into the OB (Fig. [7b, b](#Fig7){ref-type="fig"}~2~). No staining was observed with antibodies against P2X~1~, P2X~2~, P2Y~2~, and P2Y~4~ receptor subtypes (data not shown). Fig. 7Distribution of P2X~7~- and P2X~4~-like immunoreactivity in the anterior telencephalon. **a** Immunoreactivity to a P2X~7~ antibody (*green fluorescence*) and cell nuclei staining with propidium iodide (*red fluorescence*) of a slice of the anterior telencephalon is shown in a~1~. Another slice treated with the anti-P2X~7~ antibody after preadsorption with the immunizing protein and counterstained with propidium iodide is shown in a~2~. Higher magnification of the region indicated by the white rectangle in a~1~ is shown in a~3-1~--a~3-3~. Note the clear somatic staining pattern of OB cells. **b** Immunoreactivity to a P2X~4~ antibody (*b*~*1*~) of another slice of the anterior telencephalon. Higher magnification of the P2X~4~-like immunoreactivity of the PVZ (*b*~*2*~). Note the stained tubular structures starting from the lateral ventricle and extending towards the OB (see arrows). Abbreviations: *MOB* main olfactory bulb, *AOB* accessory olfactory bulb, *PVZ* periventricular zone, *lv* lateral ventricle, *mcl* mitral cell layer, *gcl* granule cell layer

Influence of the telencephalic purinergic system on the processing of olfactory information {#Sec11}
-------------------------------------------------------------------------------------------

As a last point, we investigated the possibility of a direct purinergic modulation of odorant information processing in the OB network. These experiments were performed using a nose--brain preparation (see Fig. [8a](#Fig8){ref-type="fig"}), and amino acids as olfactory stimuli. The nose--brain preparation allows to stimulate the olfactory epithelium with odorants and to simultaneously monitor the odorant-induced responses in the OB. Fig. 8Impact of the telencephalic purinergic system on the immediate processing of olfactory information in OB cells. **a** Schematic representation of a nose--brain preparation of larval *X. laevis*. The black rectangle indicates the area of the telencephalon monitored in the Ca^2+^ imaging experiments. **b** The mean response (±SEM) of all responsive cells of an OB (*n* = 45 cells) upon epithelial application of an odorant mixture (15 amino acids, each at 100 μM; see "[Materials and methods](#Sec2){ref-type="sec"}" section) was not affected by continuous OB stimulation with 5 μM 2MeSATP (b~1~, *upper row*). Compare the trace in the *gray-shaded area* (amino acid-induced responses after 10 min of 2MeSATP perfusion) with the traces to its *left* (amino acid-induced responses prior to 2MeSATP perfusion) and *right* (amino acid-induced responses after 5 min washout of 2MeSATP). The *lower row* of b~1~ shows the amino acid-induced \[Ca^2+^\]~i~ transient of a randomly chosen individual cell of the same slice. Also, the mean response (± SEM) of all amino acid-responsive cells of an OB (*n* = 23 cells) was not affected by continuous OB stimulation with 100 μM ATP (*b*~*2*~). Compare the trace in the *light red-shaded area* (amino acid-induced responses after 10 min of ATP perfusion) with the traces to its *left* (amino acid-induced responses prior to ATP perfusion) and *right* (amino acid-induced responses after 5 min washout of ATP). Prolonged application of 200 μM suramin did also not disrupt the mean response (±SEM) of all amino acid-responsive cells of an OB (*n* = 35 cells; *b*~*3*~). Compare the trace in the *yellow-shaded area* (amino acid-induced responses after 5 min of suramin perfusion) with the traces to its *left* (amino acid-induced responses prior to suramin perfusion) and *right* (amino acid-induced responses after 5 min washout of suramin). **c** The mean peak responses (±SEM), expressed as percent of control response to an epithelial application of 100 μM amino acid mixture (200 OB cells from four nose--brain preparations) in control conditions (*dark gray columns*) and after 5 to 10 min in bath solution with 5--20 μM 2MeSATP (*light gray column*) are shown in c~1~. The mean peak responses ± SEM, expressed as percent of control response to an epithelial application of 100 μM amino acid mixture \[78 OB cells/5 slices for ATP (100 μM) and 81 OB cells/4 slices for suramin 200 μM)\] in control conditions (*dark gray columns*) and after 5 to 10 min in bath solution with ATP or suramin (*light red and yellow column*) are respectively given in c~2~ and c~3.~ Abbreviations: *OE* olfactory epithelium, *ON* olfactory nerve, *OB* olfactory bulb, *AA* amino acid mixture

Continuous stimulation of the OB with purinergic agonists (2MeSATP or ATP) or the P2 receptor antagonist suramin did not disrupt the odorant-induced responses of OB cells. Figure [8b](#Fig8){ref-type="fig"} shows the mean (±SEM) intracellular amino acid-induced \[Ca^2+^\]~i~ transients of all responsive OB cells (b~1~; upper row) and the amino acid-induced \[Ca^2+^\]~i~ transient of a randomly chosen individual cell of the same slice (b~1~; lower row). The overall appearance of the responses did not notably change after OB perfusion with 2MeSATP (gray-shaded area). Similarly, also prolonged application of ATP or suramin did not notably change the mean (±SEM) amino acid-induced \[Ca^2+^\]~i~ transients of OB cells (Fig. [8b, b](#Fig8){ref-type="fig"}~2~ and b~3~). Figure [8c](#Fig8){ref-type="fig"} (c~1~--c~3~) summarizes the results obtained from all amino acid-responding OB cells from various nose--brain preparations treated with 2MeSATP, ATP and suramin, respectively.

Discussion {#Sec12}
==========

The purinergic system employs extracellular purines and pyrimidines as signaling molecules \[[@CR9]\]. In the nervous system, both neurons as well as glial cells have been shown to express various subtypes of purinergic receptors \[[@CR14]\]. The purinergic receptors of many brain regions have been thoroughly characterized, and the effects of their activation intensively studied \[[@CR14], [@CR30]\]. However, the information available about the purinergic system of the OB and the neurogenic PVZ is rather limited. There is evidence for P1 receptors \[[@CR16]\], P2X receptors (P2X~2~: \[[@CR31]--[@CR33]\]; P2X~4~: \[[@CR34]--[@CR36]\]; P2X~5~: \[[@CR37]\]; P2X~6~: \[[@CR35], [@CR38]\]; P2X~7~: \[[@CR39]\]) and P2Y receptors (P2Y~1~: \[[@CR40]\]; P2Y~2~: \[[@CR33]\]) in the murine OB and for P2X receptors (P2X~1-6~: \[[@CR41]\]; P2X~2~: \[[@CR32]\]; P2X~6~: \[[@CR35], [@CR38]\]; P2X~7~: \[[@CR39], [@CR42]--[@CR44]\]) in the murine PVZ. Ectonucleotidases, enzymes that are located at the cell surface and hydrolyze nucleotides to the respective nucleoside, have also been found in these areas \[[@CR15]\]. The above evidence is almost exclusively based on mRNA and protein profiles. Pharmacological studies are almost completely missing, and the physiological relevance of the purinergic system in these brain regions is still elusive. Only two studies describe functional purinergic receptors in these brain regions. Astrocytes in the murine OB have been shown to express functional A~2A~ and P2Y~1~ receptors \[[@CR16]\], and cells of the PVZ of the murine lateral ventricles have been reported to express functional P2X~7~ receptors \[[@CR44]\]. Here, we set out to describe the organization of the PVZ of larval *X. laevis*, and to functionally characterize the purinergic system of the OB and its neurogenic PVZ. Our suggestions about the possible physiological roles of the purinergic system in these two brain areas should aid future work dealing with these topics.

Ultrastructural analysis of the PVZ and quantification of the proliferation rate of its neuronal stem cells {#Sec13}
-----------------------------------------------------------------------------------------------------------

Cells of the PVZ of the lateral ventricle have been shown to actively proliferate in larval *X. laevis* \[[@CR4]\], and recent studies have identified these cells as true neuronal stem cells (reviewed in \[[@CR3]\]). Nevertheless, the data describing the ultrastructure of the PVZ of the anterior telencephalon in larval *X. laevis* and amphibians in general is rather limited. In the present study, we set out to describe the architecture of this brain area and to get knowledge about the normal proliferation rate of its neuronal stem-/progenitor cells. The different morphology of the PVZ cells and the cells of the adjacent OB allowed to determine the borders between these two brain areas (see Fig. [1](#Fig1){ref-type="fig"}). This was very important for the further experiments of the present work. The PVZ of the anterior and medial part of the lateral ventricles consists of four to five cell layers with no apparent ependymal epithelium. This general appearance resembles that of the embryonic ventricular zone of higher vertebrates \[[@CR45], [@CR46]\]. In contrast, the PVZ situated laterally to the ventricle is thinner, with only one to two cell layers, resembling the typical ependymal ventricle lining present in adult higher vertebrates \[[@CR45], [@CR46]\]. The occurrence of mitotic cells and the presence of cells with chromatin in different states of aggregation showed that cells of the PVZ actively proliferate. Virtually all of the cells in close contact with the ventricular lumen are devoid of cilia or microvilli. In higher vertebrates, cells contacting the ventricular lumen have been shown to be ciliated \[[@CR7], [@CR8], [@CR47]\]. Only very few cells in direct contact with the ventricles displayed a single cilium. Similar cells with a single primary cilium have been described in the adult ventricular zone of higher vertebrates. These cells have been reported to be related to radial glia, to actively proliferate and to produce new neurons and neuroblasts \[[@CR7], [@CR8]\]. The presence of large cytoplasmic expansions into the ventricular lumen and some multivesicular protrusions expanding into the ventricle suggest that cell material is releases into the lateral ventricles. Similar protrusions have been described in embryonic and adult cells lining the cerebral ventricles in several other species \[[@CR48]--[@CR50]\]. A more thorough description of the PVZ of larval *X. laevis* and a detailed classification of the different cell types populating this brain area was beyond the scope of this study. Future work will certainly bring more insight in the functional organization of the larval PVZ of this species.

To further identify the border between the PVZ and the OB and to quantify the proliferative capacity of the PVZ cells, we adopted a BrdU incorporation assay. It is known that proliferating cells actively incorporate BrdU \[[@CR24]\]. Therefore, the location of BrdU-positive cells allowed an identification of the approximate borders between the two regions (see Fig. [2](#Fig2){ref-type="fig"}). We thereby chose an adequately long time window to stain enough cells in the PVZ, but not long enough to permit stained cells to migrate into the OB. Remarkably, more than 40% of the cells within the PVZ were BrdU-positive 24 h after the injection of BrdU. This shows that the proliferation rate of neural stem/progenitor cells in larval *X. laevis* is extremely high.

Responses to nucleotides and functional investigation of the involved purinergic receptors {#Sec14}
------------------------------------------------------------------------------------------

Application of 2MeSATP and ATP, two nucleotides known to activate many purinergic receptor subtypes \[[@CR9]\], induced strong \[Ca^2+^\]~i~ increases in both, OB and PVZ cells. The fact that suramin and PPADS, two frequently used P2 receptor antagonists \[[@CR9]\], attenuated these responses in both cell pools confirmed the involvement of purinergic receptors.

In the OB, glutamate mediates most or all excitatory synaptic interactions between the different cells populating this area of the brain via ionotropic receptors \[[@CR1], [@CR25]\]. Also, it has been reported that activation of purinergic receptors can induce neurotransmitter release, including glutamate, from neuronal \[[@CR26], [@CR27]\] and glial cells \[[@CR26], [@CR28], [@CR29]\]. Therefore, we thought it would be necessary to exclude a possible contribution of ionotropic glutamate receptor activation, especially in the \[Ca^2+^\]~i~ increases recorded in cells of the OB. To do so, we compared ATP-induced \[Ca^2+^\]~i~ transients of cells of the anterior telencephalon, with and without the AMPA and NMDA receptor antagonist CNQX and APV in the bath solution. Blocking the ionotropic glutamate receptors did not significantly change the peak responses of cells of the anterior telencephalon.

To get a first indication of which receptor subtypes are involved, we investigated the effect of the omission of calcium from the extracellular solution. Although in Ca^2+^-free bath solution the 2MeSATP- and ATP-induced \[Ca^2+^\]~i~ increases were significantly reduced in both brain regions, in all of the slices tested the reduction was consistently greater in the OB. While PVZ cells of all slices tested clearly retained some residual responses, in the vast majority of OB cells the responses were virtually abolished. This faint but clear difference between the two cell pools strongly suggested that the nucleotide-induced \[Ca^2+^\]~i~ increases were almost entirely due to activation of ionotropic P2X receptors in OB cells, while in the PVZ evidently a combination of ionotropic (P2X) and metabotropic purinergic receptors (P1 and/or P2Y receptors) contributed to the responses.

To verify this supposition and in the attempt to find clear differences in the purinergic receptor expression in the OB and the PVZ, we compared the efficacy of nine known purinergic agonists (see "[Materials and methods](#Sec2){ref-type="sec"}" section). Significant differences could be observed with adenosine, ADP and ATP. Thereby, adenosine and ADP are particularly interesting. Both agonists were virtually inactive in the OB, while they induced considerable \[Ca^2+^\]~i~ increases in the PVZ. Although also ATP induced significantly stronger responses in cells of the PVZ, it is less adequate to differentiate between the two regions, as it induced strong responses also in the OB. α,β-MeATP and UTP were only very weakly active in both brain regions. β,γ-MeATP and uridine were completely inactive. 2MeSATP elicited strong but not significantly different \[Ca^2+^\]~i~ increases in cells of the OB and the PVZ. Also, BzATP elicited clear but not significantly different \[Ca^2+^\]~i~ increases in both brain regions, but it was apparently more effective in the OB.

The obtained agonist data does not allow to exactly identify the purinergic receptor subtypes involved in the Ca^2+^ signaling mechanisms in the anterior telencephalon of larval *X. laevis*, but it certainly allows a gross classification of the subtypes that are present in the different brain zones.

The virtually complete absence of 2MeSATP- and ATP-induced responses in Ca^2+^-free extracellular solution together with the failure to elicit responses with adenosine, a selective P1 receptor agonist, strongly suggests that OB cells express almost exclusively ionotropic P2X receptors \[[@CR9]\]. The very faint UTP- and ADP-mediated \[Ca^2+^\]~i~ increases could suggest a very weak expression of P2Y receptor subtypes \[[@CR12], [@CR51]\]. The presence of very few P2Y receptor subtypes on some cells of the OB could also explain the very faint residual nucleotide-induced responses in Ca^2+^-free extracellular solution. The agonist responses of OB cells are not consistent with that reported for any of the seven known P2X subtypes \[[@CR9], [@CR10]\], suggesting that OB cells express multiple P2X subtypes. ATP, known to activate all known P2X receptor assemblies \[[@CR10], [@CR52], [@CR53]\], was less potent than 2MeSATP. Already at concentrations of 5 to 10 μM 2MeSATP induced stronger responses than 50 μM ATP (Fig. [3b](#Fig3){ref-type="fig"}). This is an interesting result and apparently rather specific for the OB of larval *X. laevis*, as at most P2X subtypes in many species ATP is at least equipotent to 2MeSATP \[[@CR9], [@CR10], [@CR52], [@CR53]\]. BzATP, in turn, induced stronger responses than ATP. As BzATP has a higher potency than ATP only at the P2X~7~ subtype \[[@CR10], [@CR52], [@CR53]\], this result strongly suggest the presence of the P2X~7~ subtype in the OB.

In contrast to the OB cells, cells of the PVZ consistently retained some residual 2MeSATP- and ATP-induced \[Ca^2+^\]~i~ transients in Ca^2+^-free extracellular solution. This is a strong indication that in addition to ionotropic P2X subtypes, PVZ cells also express metabotropic purinergic receptors, known to be coupled to intracellular cascades linked to calcium release from internal stores \[[@CR9], [@CR12], [@CR51]\]. The fact that also in the PVZ the omission of extracellular calcium in the bath solution significantly reduced the nucleotide-induced responses shows that the major fraction of purinergic receptors are P2X subtypes. On the other hand, the responses to adenosine, a selective agonist for P1 receptors \[[@CR9], [@CR54]\], nicely show that PVZ cells express also functional P1 receptors. 2MeSATP was the most potent agonist also in cells of the PVZ. The fact that responses to ADP were in the range of those to ATP suggests that PVZ cells express at least one P2Y subtype highly sensitive to ADP \[[@CR12], [@CR51]\]. The faint UTP-mediated \[Ca^2+^\]~i~ increases in PVZ cells are also in line with the expression of P2Y subtypes \[[@CR12], [@CR51]\]. BzATP also induced clear responses in the PVZ. This could suggest that also PVZ cells express P2X~7~ subtypes \[[@CR52], [@CR53]\], but also other P2X subtypes have been shown to be sensitive to BzATP \[[@CR10], [@CR12], [@CR52], [@CR53]\].

Immunohistochemical localization of purinergic receptors {#Sec15}
--------------------------------------------------------

We obtained positive P2X~7~- and P2X~4~-like stainings in the anterior telencephalon of larval *X. laevis*. No clear stainings were achieved with antibodies against P2X~1~, P2X~2~, P2Y~2~, and P2Y~4~ receptor subtypes. The antibody against the P2X~7~ subtype gave a clear somatic staining pattern in both OB and PVZ cells. This result is in line with our calcium imaging data that strongly suggested the presence of the P2X~7~ subtype. The successful P2X~4~-like staining pattern suggests an expression of also this subtype. Thereby, the observed P2X~4~-positive tubular structures starting from the ependymal layer of the lateral ventricle and extending through the PVZ into the OB could represent appendages of radial glia-like cells, or other proliferating precursor cells \[[@CR6], [@CR7], [@CR55], [@CR56]\]. These cells have been shown to possess a morphology resembling the observed structures \[[@CR7], [@CR55], [@CR56]\]. This fits also very well to our observations of the ultrastructure of the PVZ, which suggested the presence of radial glia-like cells. As the used antibodies have been raised against rat P2 receptors, especially the negative results should be interpreted with caution. In the future, antibodies specifically raised against *X. laevis* purinergic receptors, in situ hybridization, or single-cell PCR experiments will hopefully provide a conclusive insight about the individual purinergic receptors subtypes expressed in the OB and the neurogenic PVZ.

Together, our pharmacological and immunohistochemical data clearly show that cells of the OB and the PVZ of larval *X. laevis* express purinergic receptors. We got strong evidence that OB cells almost exclusively express ionotropic P2X subtypes, and that cells of the PVZ most likely express a combination of ionotropic P2X and metabotropic P1 and P2Y subtypes. The exact identification of specific purinergic subtypes is inherently difficult, particularly in lower vertebrates such as amphibians. Nevertheless, the collective evidence of the present study permits a relatively clear survey of which purinergic receptor families are expressed in the anterior telencephalon, and more importantly revealed significant differences in the expression profile of purinergic receptors and the nucleotide-induced response behavior of cells of the OB and the PVZ. This knowledge will certainly aid future work dealing with questions regarding the physiological implication of the purinergic system in the anterior telencephalon of larval *X. laevis*.

On the physiological functions of the purinergic system in the anterior telencephalon {#Sec16}
-------------------------------------------------------------------------------------

**Olfactory bulb** Long-term application of purinergic agonists and antagonists did not apparently modulate odorant-induced responses of OB cells. This strongly suggests that unlike other signaling systems, such as the noradrenergic or the GABAergic system (for a review see \[[@CR25]\]), the purinergic system is most probably not involved in the immediate processing of olfactory information in the OB of larval *X. laevis*. Of course, more focused studies will be necessary to completely rule out an involvement of the purinergic system in the fine-tuning of olfactory information, but the results of the present study gave no indication in this direction. The presence of the P2X~7~ subtype rather indicates that nucleotide-induced \[Ca^2+^\]~i~ signaling is involved in the sorting of bulbar interneurons. In the neuronal network of the OB a subset of interneurons are constantly renewed throughout the animals' life \[[@CR1], [@CR57]\], and cell death through apoptosis has been shown to play a crucial role in the lifelong cellular turnover \[[@CR1], [@CR58], [@CR59]\]. On the other hand, perturbations of \[Ca^2+^\]~i~ have been shown to be involved in the initiation of cell death through apoptosis \[[@CR60], [@CR61]\], and the activation of the P2X~7~ receptor has been brought into relation with the initiation of apoptosis in a variety of cells types \[[@CR62], [@CR63]\]. Among all purinergic receptors, the P2X~7~ subtype has an interesting and unique characteristic. If activated briefly, it behaves like a non-selective cation channel, but a prolonged activation leads to the formation of a large non-selective pore permeable to molecules of up to 900 Da in size, including calcium \[[@CR64]\]. It is therefore plausible that P2X~7~ signaling is involved in the induction of apoptosis in OB cells that need to be sorted. To substantiate this assertion, future detailed studies focusing specifically on the involvement of this receptor in mechanisms regulating the cell turnover in the OB will be necessary.

**Periventricular zone of the lateral ventricles** Many molecules and their receptors have been shown to be involved in the regulation of neurogenesis \[[@CR65], [@CR66]\]. There is some evidence that also purinergic receptors might be involved (for a review, see \[[@CR67]\]), but nucleotides to date are certainly among the least investigated groups of regulatory molecules. It is known that ependymal cells lining the murine ventricular system express purinergic receptors \[[@CR14], [@CR41], [@CR42]\] and nucleotide-degrading enzymes \[[@CR15]\]. It has also been shown that neurospheres derived from the adult mouse subventricular zone express metabotropic P2Y receptors and ectonucleotidases \[[@CR68]\]. Application of nucleotides evoked fast \[Ca^2+^\]~i~ transients, and augmented cell proliferation in co-operation with growth factors \[[@CR68]\]. Also neuronal progenitors of the subgranular zone are known to respond to application of ATP, most probably via ionotropic P2X receptors \[[@CR69], [@CR70]\]. Another very recent study showed that cells of the PVZ along the lateral ventricle express functional P2X~7~ receptors \[[@CR44]\]. But the present study is the first detailed functional in situ analysis of the purinergic system of a vertebrate PVZ. We found evidence that PVZ cells of larval *X. laevis* express a complex web of purinergic receptor subtypes, and that application of nucleotides induces characteristic \[Ca^2+^\]~i~ transients in these cells. In various steps of the cell cycle \[Ca^2+^\]~i~ increases are important \[[@CR71]\] and more specifically it is also known that \[Ca^2+^\]~i~ changes induced by P2Y receptor activation are essential for the transition from the G~1~ to the S and M phases of the cell cycle \[[@CR72]\]. It might therefore be speculated that nucleotide-induced \[Ca^2+^\]~i~ changes in neurogenic brain areas are deeply involved in the control of the proliferation of neuronal stem cells. The finding that P1, P2X as well as P2Y purinergic receptor subtypes are present in the PVZ of larval *X. laevis*, suggests that different nucleosides and nucleotides are likely involved in the fine-tuning of neuronal differentiation. Future detailed studies, specifically focusing on the interplay of the different purinergic receptor subtypes, but also on the interplay of the purinergic system with other regulatory systems will certainly bring more insight.As a last point, we would like to focus on the anatomical difference in the location of the telencephalic neurogenic areas between *X. laevis* and higher vertebrates. In embryos and adults of higher vertebrates, such as mammals, OB interneurons derive from a neuronal precursor cell pool situated at a certain distance from the OB. In embryos, interneurons migrate into the OB from the lateral ganglionic eminence. In adults, they derive from the subventricular zone and migrate to the OB following the rostral migratory stream. In some species, neuronal precursor cells have to cover distances up to several centimeters to reach the OB (for a review see \[[@CR1]\]). In *X. laevis* a neuronal precursor cell pool directly borders the OB. Newborn interneurons can readily be integrated into the OB without traveling long distances. This anatomic peculiarity could certainly be of advantage for future studies dealing with basic mechanisms involved in the regulation of neurogenesis in general and the neuronal turnover in the OB in particular. In this context, it will of course be essential to investigate whether the purinergic system of the anterior telencephalon persists also in adult *X. laevis*, and whether in the adult system it is involved in the same physiological processes as in the larvae.
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